skip to main content

Proton Beam Therapy — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardCNS TumoursProton Beam TherapySCE Medical Oncology

A sacral chordoma requires a high radiotherapy dose but abuts bowel, sacral nerve roots and other dose-limiting normal tissues. Which statement most accurately justifies specialist consideration of proton rather than photon planning without overstating the evidence?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DLower exit and integral normal-tissue dose can improve the high-dose therapeutic ratio

The relevant advantage is dose distribution: proton range and rapid distal fall-off can reduce dose beyond the target and lower integral normal-tissue exposure when high-dose treatment lies beside critical structures. Protons still have entrance dose, range uncertainty and full planning requirements; their clinical RBE is not several-fold higher, and NHS England explicitly notes that they are not superior for most cancers. The decision therefore rests on a specialist comparative plan and therapeutic ratio, not a universal claim.

Reference: NHS England: proton beam therapy commissioning information (Current NHS England information, accessed August 2026): https://www.england.nhs.uk/commissioning/spec-services/highly-spec-services/pbt/